

Our team of experienced scientists and researchers brings deep expertise across a broad range of disciplines, delivering high-quality, reliable results tailored to the unique needs of each client. Whether you’re in early-stage research or preclinical development, we work as an extension of your team — combining scientific rigor with a collaborative, flexible approach.

Founded in 2017, GemPharmatech has rapidly grown to become Asia’s largest provider of laboratory mouse models. Our state-of-the-art facilities and dedicated team of scientists support pharmaceutical companies, biotechnology firms, and academic institutions worldwide.
Headquarters: Nanjing, China
Global Operations


GemPharmatech is a world leader in gene editing and model creation, offering a library of over 30,000 models — including KO/cKO, humanized, immunodeficient, and germ-free mice. With decades of combined expertise using advanced gene editing technologies, our scientists deliver precise, validated models tailored to your exact research needs.
KO/cKO
Knockout Models
Humanized
Humanized Models
Immunodeficient
NCG & Variants
Germ-Free
Axenic Models

Located in the heart of San Diego’s Sorrento Valley biotech hub, this 13,000 sq. ft. facility features a high-spec vivarium, wet laboratory space, ABSL-1 and ABSL-2 capabilities, and capacity for more than 4,000 cages, supporting custom breeding, preclinical efficacy studies, and humanized model services.

Specialized in fully human antibody discovery platform and therapeutic development.

Located in Seongsu-dong, Seoul, this site operates an established local office designed to support the efficient execution of projects for Korean clients. Through close collaboration between headquarters-based scientific teams and local business development managers, the Seoul office enables streamlined communication, faster project coordination, and responsive on-the-ground support for regional partners. The office aims to deliver high-quality, efficient CRO services and comprehensive support throughout the study lifecycle.

Based in Hong Kong, China, this site serves as an overseas R&D and manufacturing base, leveraging Hong Kong’s advantages as an international free port and a biomedical industry hub. Established in 2024, it aims to capture rapidly growing market opportunities in the Asia-Pacific and European regions, expand global biomedical trade channels, participate in international competition, and enhance the global presence of the company’s products and services.


Get in touch with our team
Phone
400-9660-890
info@gempharmatech.com
Address
Nanjing,Jiangsu,China
Let us know which event you're attending and we'd be happy to connect with you.